407 related articles for article (PubMed ID: 12784674)
1. [Dystroglycan linkage and muscular dystrophy].
Shimizu T
Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
[TBL] [Abstract][Full Text] [Related]
4. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.
Moore SA; Saito F; Chen J; Michele DE; Henry MD; Messing A; Cohn RD; Ross-Barta SE; Westra S; Williamson RA; Hoshi T; Campbell KP
Nature; 2002 Jul; 418(6896):422-5. PubMed ID: 12140559
[TBL] [Abstract][Full Text] [Related]
5. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP
Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558
[TBL] [Abstract][Full Text] [Related]
6. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
Toda T
Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation defects: a new mechanism for muscular dystrophy?
Grewal PK; Hewitt JE
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R259-64. PubMed ID: 12925572
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin.
Yamamoto T; Kato Y; Kawaguchi M; Shibata N; Kobayashi M
Med Electron Microsc; 2004 Dec; 37(4):200-7. PubMed ID: 15614444
[TBL] [Abstract][Full Text] [Related]
9. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycan.
Xiong H; Kobayashi K; Tachikawa M; Manya H; Takeda S; Chiyonobu T; Fujikake N; Wang F; Nishimoto A; Morris GE; Nagai Y; Kanagawa M; Endo T; Toda T
Biochem Biophys Res Commun; 2006 Dec; 350(4):935-41. PubMed ID: 17034757
[TBL] [Abstract][Full Text] [Related]
10. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
Matsumura K; Campbell KP
Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
[TBL] [Abstract][Full Text] [Related]
11. Protein glycosylation in disease: new insights into the congenital muscular dystrophies.
Martin-Rendon E; Blake DJ
Trends Pharmacol Sci; 2003 Apr; 24(4):178-83. PubMed ID: 12707004
[TBL] [Abstract][Full Text] [Related]
12. Defective glycosylation in muscular dystrophy.
Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
[TBL] [Abstract][Full Text] [Related]
13. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
Murakami T; Nishino I
Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
[TBL] [Abstract][Full Text] [Related]
14. The childhood muscular dystrophies: making order out of chaos.
Tsao CY; Mendell JR
Semin Neurol; 1999; 19(1):9-23. PubMed ID: 10711985
[TBL] [Abstract][Full Text] [Related]
15. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
[TBL] [Abstract][Full Text] [Related]
16. Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy.
Toda T; Kobayashi K; Takeda S; Sasaki J; Kurahashi H; Kano H; Tachikawa M; Wang F; Nagai Y; Taniguchi K; Taniguchi M; Sunada Y; Terashima T; Endo T; Matsumura K
Congenit Anom (Kyoto); 2003 Jun; 43(2):97-104. PubMed ID: 12893968
[TBL] [Abstract][Full Text] [Related]
17. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.
Martin PT
Glycobiology; 2003 Aug; 13(8):55R-66R. PubMed ID: 12736199
[TBL] [Abstract][Full Text] [Related]
18. Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice.
Saito F; Masaki T; Saito Y; Nakamura A; Takeda S; Shimizu T; Toda T; Matsumura K
J Neurochem; 2007 Jun; 101(6):1712-22. PubMed ID: 17326765
[TBL] [Abstract][Full Text] [Related]
19. [Hint and luck for identification of a gene for Fukuyama muscular dystrophy, fukutin].
Toda T
Rinsho Shinkeigaku; 2007 Nov; 47(11):743-8. PubMed ID: 18210789
[TBL] [Abstract][Full Text] [Related]
20. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?
Matsumura K; Saito F; Yamada H; Hase A; Sunada Y; Shimizu T
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):751-62. PubMed ID: 10541473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
